Diagnostic HYBRIDS, founded in 1983 in Athens, OH, invents, develops, manufactures, and sells innovative diagnostic and analytical products for a wide range of viral respiratory diseases, herpes virus infections, and other specific viral and thyroid diseases. The company also develops and commercializes innovative and genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry, with an initial focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. Diagnostic Hybrids Life Science Division provides products and services for non-diagnostic applications including in vitro toxicology and metabolism products and services, including primary hepatocytes and hepatocyte-based assays.